United States · FDA National Drug Code directory
Topcare ClearLax
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76162-119_57254ac5-729d-4aae-863d-b57a67053aec
- Product NDC
- 76162-119
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Polyethylene Glycol 3350
- Labeler
- Topco Associates LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240130
- Source listing expiry
- 20261231
Source-listed ingredients
- POLYETHYLENE GLYCOL 3350 — 17 g/17g
These values do not establish equivalence or a dose recommendation.
Packages
- 238 g in 1 BOTTLE (76162-119-02) · 76162-119-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →